Despite having gone through this before with her first son, Yusof, and despite the doctors explaining that this was a gene ...

Hunter syndrome results from the absence of an enzyme needed to break down cellular waste. Without it, waste builds up in the body, causing progressive damage to various systems.

In 2021, the FDA granted Fast Track designation to tividenofusp alfa for the treatment of patients with Hunter syndrome. In 2022, the European Medicines Agency granted Priority Medicines ...

Haliza Md Kasim’s eyes widened. Despite having gone through this before with her first son, Yusof, and despite the doctors ...

DNLI has had a good run in the past year on positive pipeline updates. A potential approval of its Hunter Syndrome drug should be a boost. However, recent pipeline setbacks warrant caution.

Endovascular treatments have also emerged as a viable option for managing Bow Hunter's Syndrome. One report described a patient who underwent endovascular parent artery occlusion, successfully ...

Hunter syndrome treatment is on a strong growth trajectory, with projections indicating an increase from $861.5 million in 2024 VANCOUVER, BRITISH COLUMBIA, CANADA ...